Prenosis Inc.

Prenosis is an artificial intelligence company enabling precision medicine in acute care. It leverages the Immunix precision-medicine platform to develop new precision-medicine tools and implement them in real time within clinical workflows. The company’s offerings include ImmunoScore, which received FDA De Novo marketing authorization in 2024, supporting Prenosis’s mission to bring personalized, data-informed care to patients and clinicians at the point of care.